Hledání článků

Fernandez‑Juarez G, Perez JV, Caravaca‑Fontán F, et al.; Spanish Group for the Study of Glomerular Diseases (GLOSEN). Duration of treatment with corticosteroids and recovery of kidney function in acute interstitial nephritis.

Clin J Am Soc Nephrol 2018;13:1851–1858.

Jones RB, Hiemstra TF, Ballarin J, et al.; European Vasculitis Study Group (EUVAS). Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA‑associated vasculitis: a randomised, non‑inferiority trial.

Ann Rheum Dis 2019;78:399–405.

Madsen CV, Granqvist H, Petersen HJ, et al. Age‑related renal function decline in Fabry disease patients on enzyme replacement therapy: a longitudinal cohort study.

Nephrol Dial Transplant 2018;10:1–9.

Jaber S, Paugam C, Futier E, et al.; BICAR‑ICU Study Group. Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR‑ICU): a multicentre, open‑label, randomised controlled, phase 3 trial.

Lancet 2018;392:31–40.

Zhang Z, Zhu C, Mo L, Hong Y. Effectiveness of sodium bicarbonate infusion on mortality in septic patients with metabolic acidosis.

Intensive Care Med 2018;44:1888–1895

Kraus D, von Jeinsen B, Tzikas S, et al. Cardiac Troponins for the Diagnosis of Acute Myocardial Infarction in Chronic Kidney Disease.

J Am Heart Assoc 2018;7:e008032.

Calderon‑Margalit R, Golan E, Twig G, et al.

History of Childhood Kidney Disease and Risk of Adult End‑Stage Renal Disease. N Engl J Med 2018;378:428–438.

Gomez Mendez LM, Cascino MD, Garg J, et al.

Peripheral blood B cell depletion after rituximab and complete response in lupus nephritis. Clin J Am Soc Nephrol 2018;13:1502–1509

Nataatmadja MS, Johnson DW, Pascoe EM, et al.;

balANZ Trial Investigators. Associations between peritoneal glucose exposure, glucose degradation product exposure, and peritoneal membrane transport characteristics in peritoneal dialysis patients: secondary analysis of the balANZ trial.Perit Dial Int 2018;38:349–355.

Schaefer F, Ardissino G, Ariceta G, et al.;

Global aHUS Registry. Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome.

Kidney Int 2018;94:408–418.

Pisani A, Riccio E, Bruzzese D, Sabbatini M. Metformin in autosomal dominant polycystic kidney disease: experimental hypothesis or clinical fact?

BMC Nephrol 2018;19:282.

Williams B, Mancia G, Spiering W, et al.

2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ESC Task Force for the Management of Arterial Hypertension.

J Hypertens 2018;36:1953–2041.

Beckwith H, Kingsbury M, Horsburg J. Why do people choose nephrology? Identifying positive motivators to aid recruitment and retention.

Clin Kidney J 2018;11:599–604.